Smartwatch with heart rate monitor icon on colorful diagonal striped background
Medtech Case Study

Patient Input Informs the Creation of a New Patient-Reported Outcome

Use of Patient Engagement to Develop and Validate a Novel Patient-Reported Outcome
 

Source
National Health Council

Link
Patient-Focused Medical Product Development Case Examples
 

Description of Case Study

Incyte developed and validated a patient-reported outcome (PRO) measure (Myelofibrosis Symptom Assessment Form, version 2.0) through patient input and testing aligned with US Food and Drug Administration (FDA) guidance. The purpose of engagement was to ensure measures reflected patient experience and could support use as a clinical trial endpoint. This case is frequently cited by the FDA as a successful example of clinical outcome assessment development.
 

Quick Facts

Organization name: Incyte Corporation
Organization type: pharmaceutical company
Product category: pharmaceutical/biological product
Region(s) of patient engagement activities: North America: United States
Total product life cycle stage(s): clinical/testing; evaluation/authorization

 

Product Type(s)

  • pharmaceutical/biological product
     

Product Medical Specialty Area(s)

  • hematology
     

Stakeholders

  • patients and caregivers
  • patient organizations
  • regulators
     

Methods and Sources of Patient Input

  • interviews/focus groups/surveys
  • clinical outcome assessments (PROs, clinician-reported outcomes, observer-reported outcomes)
     

Impact of Patient Engagement

Through patient engagement activities such as patient interviews, cognitive debriefing, and validation testing, the product developer was able to meet the FDA guidance requirements to use a novel PRO measure as a clinical trial end point.

Reported areas of impact include:

  • Development of PRO instrument: Patient input informed the design of a symptom assessment tool.
  • Regulatory-aligned validation: Engagement supported development consistent with FDA PRO guidance.
  • Use in clinical trials: The PRO was used to measure treatment benefit in trials.